Clinical Trial

Precision Genomics Medicine Biobank

Study acronym: PRECISE
Recruiting
View on ClinicalTrials.gov →
Summary
The immediate goal of this study is to collect biological samples (i.e., tissue and/or fluid), clinical information, and laboratory data from disease and non-disease subjects seen at Intermountain Healthcare affiliated facilities. The long-term goal is to annotate tissue and/or fluid biomarker data to clinical information and laboratory data for the purpose of improving health care delivery and prognostic potential.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2019-12-03; most recent amendment 2022-04-18.
Trial Details
NCT Number NCT04187729
Lead Sponsor Intermountain Health Care, Inc.
Conditions Any Disease Condition and Reportedly-healthy Subjects
Enrollment 100,000 participants
Start Date 2017-10-24
Primary Completion 2067-10-24 (estimated)
Study Completion 2077-10-24 (estimated)
Updated on ClinicalTrials.gov 2022-04-20